Principal component analysis of proton nuclear magnetic resonance spectra of lipoprotein fractions from patients with coronary heart disease and healthy subjects

Citation
Tf. Bathen et al., Principal component analysis of proton nuclear magnetic resonance spectra of lipoprotein fractions from patients with coronary heart disease and healthy subjects, SC J CL INV, 59(5), 1999, pp. 349-360
Citations number
31
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
ISSN journal
00365513 → ACNP
Volume
59
Issue
5
Year of publication
1999
Pages
349 - 360
Database
ISI
SICI code
0036-5513(199908)59:5<349:PCAOPN>2.0.ZU;2-A
Abstract
Blood plasma was drawn from 12 healthy subjects and 12 patients with corona ry heart disease (CHD). The lipoproteins were fractionated by serial ultrac entrifugation. The methyl and methylene regions of proton nuclear magnetic resonance (1H NMR) spectra of the lipoproteins very low density lipoprotein (VLDL), low density lipoprotein (LDL);and high density lipoprotein (HDL) w ere analysed by principal component analysis (PCA). Grouping patterns in th e score plots and the profiles of the principal components revealed several characteristics of the spectra. LDL subparticle size among the CHD group w as consistently skewed against smaller, denser subparticles. This feature w as independent of the concentration of LDL cholesterol. Analysis of the LDL spectra by soft independent modelling of class analogy (SIMCA) showed that none of the samples from the CHD group could be assigned as healthy subjec ts (p < 0.05). We also found that the samples from the healthy subjects wer e associated with a higher concentration of HDL cholesterol and larger VLDL subparticles. The approach presented, in which PCA is used in combination with NMR spectroscopy, might be implemented in clinical studies to give inf ormation about lipoprotein subparticle distribution and lipid content.